Tenet Reports Results for the Fourth Quarter Ended December 31, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Tenet Healthcare (THC) Tops Q4 EPS by 15c, Offers Outlook
February 26, 2018 4:22 PM ESTTenet Healthcare (NYSE: THC) reported Q4 EPS of $1.40, $0.15 better than the analyst estimate of $1.25. Revenue for the quarter came in at $4.98 billion versus the consensus estimate of $4.87 billion.
GUIDANCE:
Tenet Healthcare sees Q1 2018 EPS of $0.73-$1.07, versus the consensus of $1.02.... More
